Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1167 of 5804
-
Virtual program aims to stop intimate partner violence in young parents
Prevention Recruiting nowThis project will study virtual delivery of Safe Dates for Young Parents (SDYP), a 10-session, group-based intimate partner violence (IPV) prevention program tailored for adolescents and young adults who are pregnant or parenting. This program has the potential to improve the hea…
Phase: NA • Sponsor: RTI International • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Video game controlled by brain waves could revolutionize cognitive testing for kids with disabilities
Diagnosis Recruiting nowThis project aims to validate an EEG-based brain-computer interface (BCI) game as a cognitive assessment tool for children with motor impairments. Traditional cognitive assessments often rely on motor responses, which may underestimate the abilities of children with limited mobil…
Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New hope for OCD? brain zaps plus therapy put to the test
Disease control Recruiting nowThis study will test how people with OCD respond to a type of noninvasive brain stimulation, repetitive Transcranial Magnetic Stimulation (rTMS), when it is combined with psychotherapy. Participants will either engage in Exposure and Response Prevention (ERP) Therapy or supportiv…
Phase: NA • Sponsor: Adam Frank • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New cancer drug targets two proteins at once in early trial
Disease control Recruiting nowThis study is a first-in-human (FIH), Phase 1a/1b study of BG-C0902, a fully humanized anti-epidermal growth factor receptor (EGFR) and anti-mesenchymal-epithelial transition (MET) antibody, conjugated via an enzymatically cleavable linker to a topoisomerase 1 (TOPO1) inhibitor p…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Needles vs. delirium: could acupuncture protect Seniors' minds after surgery?
Prevention Not yet recruitingElectroacupuncture may improve cognitive function and altered consciousness, but its effect on postoperative delirium in older arthroplasty patients remains unexplored. This study aims to assess the efficacy of electroacupuncture in preventing postoperative delirium in older adul…
Phase: NA • Sponsor: Fujian Provincial Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Could a brain booster ease Parkinson's? new trial launches
Disease control Recruiting nowThe clinical manifestations of Parkinson's disease (PD), a chronic neurodegenerative condition, include resting tremor, hypokinesia, bradykinesia, stiffness and postural instability. These motor symptoms are caused by a selective loss and degeneration of dopaminergic neurons in t…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common diabetes drug ease Parkinson's?
Disease control Recruiting nowThe clinical manifestations of Parkinson's disease (PD), a chronic neurodegenerative condition, include resting tremor, hypokinesia, bradykinesia, stiffness and postural instability. These motor symptoms are caused by a selective loss and degeneration of dopaminergic neurons in t…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New cholesterol pill may help those who can't tolerate statins
Disease control Not yet recruitingBempedoic acid is an oral, non-statin LDL-cholesterol (LDL-C) lowering agent that inhibits ATP citrate lyase (ACL), upstream of HMG-CoA reductase (the enzyme inhibited by statins). MDPI +1 In patients with hypercholesterolemia who are unable to tolerate statins, or have sub-op…
Phase: PHASE3 • Sponsor: Sohaib Ashraf • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can radiation make immunotherapy work better in kidney cancer?
Knowledge-focused Recruiting nowThe goal of this multicenter observational study is to elucidate the clinical and immunological characteristics of the abscopal effect in patients with metastatic renal cell carcinoma (mRCC) receiving immune checkpoint inhibitors (ICI) combined with image-guided ultra-hypofractio…
Sponsor: Zhe Chen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Brain cell injection aims to tame seizures in Drug-Resistant epilepsy
Disease control Recruiting nowThis is an exploratory clinical trial (Protocol: UX-GIP001-101) investigating UX-GIP001 Injection, a novel cell therapy product consisting of human GABAergic interneuron progenitor cells (GIP), for treating adult patients with drug-resistant unilateral medial temporal lobe epilep…
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Wegovy's Real-World weight loss power tested in 500 korean patients
Disease control ENROLLING_BY_INVITATIONThis study is to investigate the effectiveness and safety of Wegovy (semaglutide) in Korean patients living with obesity in routine clinical practice. The purpose of this study is to investigate the change in body weight and other clinical characteristics related to body weight i…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple injection replace major surgery for ovarian cancer staging?
Diagnosis Recruiting nowThis clinical trial investigates the sentinel lymph node (SLN) technique as a less invasive alternative to conventional lymphadenectomy in patients with early-stage ovarian cancer. The primary objective is to evaluate the effectiveness, safety, and diagnostic accuracy of the SLN …
Phase: PHASE3 • Sponsor: Instituto de Investigacion Sanitaria La Fe • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Free glasses may keep minds sharp in rural seniors
Disease control Recruiting nowThe aim of this project is to explore whether vision correction can effectively slow cognitive decline in older adults. The primary question it seeks to answer is: Can providing free near and/or distance vision correction glasses to older adults with refractive errors or uncorre…
Phase: NA • Sponsor: Yuju Wu • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Umbilical cord stem cells could mend Worn-Out knees
Disease control Recruiting nowTesting the safety and efficacy of MSC from umbilical cord tissue (UC-MSC) for the treatment of cartilage damage in the knee joint
Phase: PHASE1, PHASE2 • Sponsor: BIONCaRT GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could less be more? major trial questions routine antibiotic for heart valve infections
Disease control Recruiting nowThis is a sub-study of the S. aureus Network Adaptive Platform (SNAP) trial (NCT05137119) wherein we will evaluate whether not giving rifampin in patients with probable or definite prosthetic valve endocarditis due to S. aureus is non-inferior to giving rifampin.
Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common supplement protect nerves during breast cancer treatment?
Symptom relief Completed* This study aims to investigate whether Coenzyme Q10 supplementation can reduce chemotherapy-induced peripheral neuropathy, fatigue, and pain in women with newly diagnosed breast cancer receiving paclitaxel treatment. The study will also examine the effects of Coenzyme Q10 on bi…
Phase: PHASE2 • Sponsor: Damanhour University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a 4-Week steroid course be safer for vasculitis patients?
Disease control Recruiting nowThe purpose of this study is to determine the safety and efficacy of a therapeutic regimen consisting of 4 weeks of glucocorticoids given with a combination of the usual induction agents for ANCA-associated vasculitis. The trial will compare this regimen to the current standard o…
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for toddlers with esophagus inflammation: dupilumab trial launches
Disease control Recruiting nowThis study is researching an experimental drug called dupilumab (called "study drug"). The study is focused on children with active eosinophilic esophagitis (EoE; an inflammatory disease of the esophagus) which impacts feeding and nourishment. The aim of the study is to see how …
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo pill aims to tame stubborn ulcerative colitis
Disease control Recruiting nowThe main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compared to mirikizumab alone in adult participants with moderately to severely active ulcerative colitis (UC). Study participation will last approximately 118 week…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New genetic test may predict prostate cancer drug response before surgery
Knowledge-focused Recruiting nowThe PARIS-BIO study evaluates whether a novel genomic biomarker, the PCAI ImmunoScore, can predict the response to neoadjuvant treatment with Darolutamide in patients with high-risk localized or locally advanced prostate cancer. Patients will receive Darolutamide monotherapy for …
Phase: PHASE2 • Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC